These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 36795846)

  • 21. Engineered models of the human heart: Directions and challenges.
    Stein JM; Mummery CL; Bellin M
    Stem Cell Reports; 2021 Sep; 16(9):2049-2057. PubMed ID: 33338434
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Perspective on human pluripotent stem cell-derived cardiomyocytes in heart disease modeling and repair.
    Li Q; Wang J; Wu Q; Cao N; Yang HT
    Stem Cells Transl Med; 2020 Oct; 9(10):1121-1128. PubMed ID: 32725800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human pluripotent stem cell models of cardiac disease: from mechanisms to therapies.
    Brandão KO; Tabel VA; Atsma DE; Mummery CL; Davis RP
    Dis Model Mech; 2017 Sep; 10(9):1039-1059. PubMed ID: 28883014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concise review: reprogramming strategies for cardiovascular regenerative medicine: from induced pluripotent stem cells to direct reprogramming.
    Budniatzky I; Gepstein L
    Stem Cells Transl Med; 2014 Apr; 3(4):448-57. PubMed ID: 24591731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An organ-on-a-chip model for pre-clinical drug evaluation in progressive non-genetic cardiomyopathy.
    Wang EY; Kuzmanov U; Smith JB; Dou W; Rafatian N; Lai BFL; Lu RXZ; Wu Q; Yazbeck J; Zhang XO; Sun Y; Gramolini A; Radisic M
    J Mol Cell Cardiol; 2021 Nov; 160():97-110. PubMed ID: 34216608
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generation of human cardiomyocytes for cardiac regenerative therapies: differentiation and direct reprogramming.
    Hodonsky C; Wu K; Mundada L; Si MS
    Curr Pharm Des; 2014; 20(12):2012-22. PubMed ID: 23844731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recent Progress Using Pluripotent Stem Cells for Cardiac Regenerative Therapy.
    Ichimura H; Shiba Y
    Circ J; 2017 Jun; 81(7):929-935. PubMed ID: 28603177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stem Cells: The Game Changers of Human Cardiac Disease Modelling and Regenerative Medicine.
    Parrotta EI; Scalise S; Scaramuzzino L; Cuda G
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31744081
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Next generation human skin constructs as advanced tools for drug development.
    Abaci HE; Guo Z; Doucet Y; Jacków J; Christiano A
    Exp Biol Med (Maywood); 2017 Nov; 242(17):1657-1668. PubMed ID: 28592171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Finding the rhythm of sudden cardiac death: new opportunities using induced pluripotent stem cell-derived cardiomyocytes.
    Sallam K; Li Y; Sager PT; Houser SR; Wu JC
    Circ Res; 2015 Jun; 116(12):1989-2004. PubMed ID: 26044252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heart-on-a-chip based on stem cell biology.
    Jastrzebska E; Tomecka E; Jesion I
    Biosens Bioelectron; 2016 Jan; 75():67-81. PubMed ID: 26298640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perspectives on the Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Biomedical Research.
    Mummery CL
    Stem Cell Reports; 2018 Dec; 11(6):1306-1311. PubMed ID: 30540958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modelling sarcomeric cardiomyopathies in the dish: from human heart samples to iPSC cardiomyocytes.
    Eschenhagen T; Mummery C; Knollmann BC
    Cardiovasc Res; 2015 Apr; 105(4):424-38. PubMed ID: 25618410
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arrhythmia Mechanisms in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Paci M; Penttinen K; Pekkanen-Mattila M; Koivumäki JT
    J Cardiovasc Pharmacol; 2020 Dec; 77(3):300-316. PubMed ID: 33323698
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between frataxin expression and contractility revealed by in vitro Friedreich's ataxia cardiac tissue models engineered from human pluripotent stem cells.
    Wong AO; Wong G; Shen M; Chow MZ; Tse WW; Gurung B; Mak SY; Lieu DK; Costa KD; Chan CW; Martelli A; Nabhan JF; Li RA
    Stem Cell Res Ther; 2019 Jul; 10(1):203. PubMed ID: 31286988
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromuscular disease modeling on a chip.
    Santoso JW; McCain ML
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32817118
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Induced Pluripotent Stem-Cardiac-Endothelial-Tumor-on-a-Chip to Assess Anticancer Efficacy and Cardiotoxicity.
    Weng KC; Kurokawa YK; Hajek BS; Paladin JA; Shirure VS; George SC
    Tissue Eng Part C Methods; 2020 Jan; 26(1):44-55. PubMed ID: 31797733
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A 3-D human model of complex cardiac arrhythmias.
    Williams K; Liang T; Massé S; Khan S; Hatkar R; Keller G; Nanthakumar K; Nunes SS
    Acta Biomater; 2021 Sep; 132():149-161. PubMed ID: 33713861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptation of cardiomyogenesis to the generation and maturation of cardiomyocytes from human pluripotent stem cells.
    Martyniak A; Jeż M; Dulak J; Stępniewski J
    IUBMB Life; 2023 Jan; 75(1):8-29. PubMed ID: 36263833
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subtype-specific cardiomyocytes for precision medicine: Where are we now?
    Zhao MT; Shao NY; Garg V
    Stem Cells; 2020 Jul; 38(7):822-833. PubMed ID: 32232889
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.